{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:33:10Z","timestamp":1768311190762,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methylxanthines, purine alkaloids found in plants, are found in beverages (coffee, tea, cocoa) and foods (chocolate and other cocoa-containing foods) commonly consumed worldwide. Members of this family include caffeine, theophylline and theobromine. Methylxanthines have a variety of pharmacological effects, and caffeine and theophylline are used as pharmaceuticals. Methylxanthines are metabolized in the liver predominantly by the enzyme CYP1A2. Their co-administration with CYP1A2 inhibitors may lead to pharmacokinetic interactions. Little is known about the possible drug interactions between caffeine and substrates of other CYP450 enzymes. In our study, methylxanthine fractions inhibited CYP3A4 in a concentration-dependent manner. Concomitant consumption of green tea with CYP3A4 substrates could increase the possibility of interactions, and this requires further clarification. The inhibition of CYP3A4 is not only due to the presence of catechin derivatives but methylxanthines may also contribute to this effect.<\/jats:p>","DOI":"10.1038\/s41598-019-50468-7","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T20:12:13Z","timestamp":1569528733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Isolation, analysis and in vitro assessment of CYP3A4 inhibition by methylxanthines extracted from Pu-erh and Bancha tea leaves"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-1452","authenticated-orcid":false,"given":"Kaloyan D.","family":"Georgiev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Radeva-Ilieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-0289","authenticated-orcid":false,"given":"Stanila","family":"Stoeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliya","family":"Zhelev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"issue":"6","key":"50468_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s12161-016-0724-y","volume":"10","author":"N-Y Shen","year":"2017","unstructured":"Shen, N.-Y., Zheng, S.-Y. & Wang, X.-Q. Determination of Biogenic Amines in Pu-erh Tea with Precolumn Derivatization by High-Performance Liquid Chromatography. Food Analytical. Methods 10(6), 1690\u20138, https:\/\/doi.org\/10.1007\/s12161-016-0724-y (2017).","journal-title":"Methods"},{"issue":"5","key":"50468_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2756","volume":"12","author":"M Iwasaki","year":"2010","unstructured":"Iwasaki, M. et al. Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res. 12(5), R88, https:\/\/doi.org\/10.1186\/bcr2756 (2010).","journal-title":"Breast Cancer Res."},{"key":"50468_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.14748\/ssp.v1i1.605","volume":"1","author":"K Georgiev","year":"2014","unstructured":"Georgiev, K., Zhelev, I. & Georgieva, S. Total phenolic compounds and tannins content of Bancha green tea (Camellia Sinensis) depending on extraction conditions. Scripta Scientifica Pharmaceutica 1, 48\u201351, https:\/\/doi.org\/10.14748\/ssp.v1i1.605 (2014).","journal-title":"Scripta Scientifica Pharmaceutica"},{"issue":"2","key":"50468_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","volume":"17","author":"A Nehlig","year":"1992","unstructured":"Nehlig, A., Daval, J. L. & Debry, G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev. 17(2), 139\u201370 (1992).","journal-title":"Brain Res Rev."},{"issue":"5","key":"50468_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF03259301","volume":"4","author":"P Sullivan","year":"1995","unstructured":"Sullivan, P. Theophylline. Clinical Immunotherapeutics. 4(5), 387\u201395, https:\/\/doi.org\/10.1007\/BF03259301 (1995).","journal-title":"Clinical Immunotherapeutics."},{"issue":"1","key":"50468_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00213-013-3021-0","volume":"228","author":"MJ Baggott","year":"2013","unstructured":"Baggott, M. J. et al. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology 228(1), 109\u201318, https:\/\/doi.org\/10.1007\/s00213-013-3021-0 (2013).","journal-title":"Psychopharmacology"},{"issue":"7","key":"50468_CR7","first-page":"2236","volume":"4","author":"K Georgiev","year":"2015","unstructured":"Georgiev, K., Iliev, I. & Jelev, I. Evaluation of antitumor effect of methylxanthine fraction isolated from Pu-erh tea. WJPR 4(7), 2236\u20132242 (2015).","journal-title":"WJPR"},{"issue":"7","key":"50468_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00018-003-3269-3","volume":"61","author":"G Fisone","year":"2004","unstructured":"Fisone, G., Borgkvist, A. & Usiello, A. Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences 61(7), 857\u201372, https:\/\/doi.org\/10.1007\/s00018-003-3269-3 (2004).","journal-title":"Cellular and Molecular Life Sciences"},{"key":"50468_CR9","first-page":"33","volume-title":"Methylxanthines","author":"Maurice J. Arnaud","year":"2010","unstructured":"Arnaud, M. J. Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man. In: Fredholm BB, editor. Methylxanthines. Berlin, Heidelberg: Springer Berlin Heidelberg; 33\u201391 (2011)."},{"key":"50468_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-663-05268-5_8","volume-title":"Theophylline and other Methylxanthines \/ Theophyllin und andere Methylxanthine","author":"H.-J. Hinze","year":"1982","unstructured":"Hinze, H. J. Analytic and pharmacokinetic data of natural methylxanthines and of the xanthine derivative pentoxifylline. In: Rietbrock N, Woodcock B. G., Staib A. H., editors. Theophylline and other Methylxanthines\/Theophyllin und andere Methylxanthine: Proceedings of the 4th International Symposium, Frankfurt\/M., 29th and 30th May, 1981\/Vortr\u00e4ge des 4. Internationalen Symposiums, Frankfurt\/M., 29. und 30. Mai, 1981. Wiesbaden: Vieweg\u2009+\u2009Teubner Verlag; 55\u201361 (1982)."},{"key":"50468_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.neuropharm.2012.11.029","volume":"67","author":"M Orr\u00fa","year":"2013","unstructured":"Orr\u00fa, M. et al. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology. 67, 476\u201384, https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.029 (2013).","journal-title":"Neuropharmacology."},{"issue":"6","key":"50468_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/00498259209053129","volume":"22","author":"F Berthou","year":"1992","unstructured":"Berthou, F. et al. Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22(6), 671\u201380 (1992).","journal-title":"Xenobiotica."},{"issue":"2","key":"50468_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","volume":"39","author":"JA Carrillo","year":"2000","unstructured":"Carrillo, J. A. & Benitez, J. Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications. Clinical Pharmacokinetics. 39(2), 127\u201353, https:\/\/doi.org\/10.2165\/00003088-200039020-00004 (2000).","journal-title":"Clinical Pharmacokinetics."},{"issue":"2","key":"50468_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/chromsci\/46.2.144","volume":"46","author":"B Srdjenovic","year":"2008","unstructured":"Srdjenovic, B., Djordjevic-Milic, V., Grujic, N., Injac, R. & Lepojevic, Z. Simultaneous HPLC determination of caffeine, theobromine, and theophylline in food, drinks, and herbal products. J Chromatogr Sci. 46(2), 144\u20139 (2008).","journal-title":"J Chromatogr Sci."},{"issue":"1","key":"50468_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/chromsci\/40.1.45","volume":"40","author":"MS Bispo","year":"2002","unstructured":"Bispo, M. S. et al. Simultaneous determination of caffeine, theobromine, and theophylline by high-performance liquid chromatography. J Chromatogr Sci. 40(1), 45\u20138 (2002).","journal-title":"J Chromatogr Sci."},{"issue":"12","key":"50468_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/foods6120109","volume":"6","author":"JM Sanchez","year":"2017","unstructured":"Sanchez, J. M. Methylxanthine Content in Commonly Consumed Foods in Spain and Determination of Its Intake during Consumption. Foods. 6(12), 109, https:\/\/doi.org\/10.3390\/foods6120109 (2017).","journal-title":"Foods."},{"issue":"3","key":"50468_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2133\/dmpk.DMPK-12-RG-101","volume":"28","author":"S Misaka","year":"2013","unstructured":"Misaka, S. et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet. 28(3), 244\u20139 (2013).","journal-title":"Drug Metab Pharmacokinet."},{"issue":"2","key":"50468_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.18433\/J3MS5C","volume":"19","author":"T Satoh","year":"2016","unstructured":"Satoh, T., Fujisawa, H., Nakamura, A., Takahashi, N. & Watanabe, K. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities. J Pharm Pharm Sci. 19(2), 188\u201397, https:\/\/doi.org\/10.18433\/J3MS5C (2016).","journal-title":"J Pharm Pharm Sci."},{"key":"50468_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1124\/dmd.104.000083","volume":"32","author":"JL Donovan","year":"2004","unstructured":"Donovan, J. L. et al. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 32, 906\u2013908 (2004).","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"50468_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0928-0987(01)00148-8","volume":"13","author":"GT Tucker","year":"2001","unstructured":"Tucker, G. T., Houston, J. B. & Huang, S. M. EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism\/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences. Eur J Pharm Sci. 13(4), 417\u201328 (2001).","journal-title":"Eur J Pharm Sci."},{"issue":"3","key":"50468_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0091270008331196","volume":"49","author":"P Zhao","year":"2009","unstructured":"Zhao, P. et al. Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study. J Clin Pharmacol. 49(3), 351\u20139 (2009).","journal-title":"J Clin Pharmacol."},{"issue":"7","key":"50468_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1124\/dmd.112.050732","volume":"41","author":"B Han","year":"2013","unstructured":"Han, B. et al. Optimization of drug-drug interaction study design: comparison of minimal physiologically based pharmacokinetic models on prediction of CYP3A inhibition by ketoconazole. Drug Metab Dispos. 41(7), 1329\u201338 (2013).","journal-title":"Drug Metab Dispos."},{"key":"50468_CR23","unstructured":"ICH. Topic Q2 (R1) Validation of analytical procedures: Text and methodology (CPMP\/ICH\/381\/95), 1995. November (2005)."},{"key":"50468_CR24","unstructured":"Invitrogen. Vivid\u00ae CYP450 Screening Kits Protocol. 2005, http:\/\/ulab360com\/files\/prod\/manuals\/037\/337004pdf (Accessed 10 Dec 2018)."},{"issue":"12","key":"50468_CR25","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1124\/dmd.107.017236","volume":"35","author":"DA Fairman","year":"2007","unstructured":"Fairman, D. A., Collins, C. & Chapple, S. Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation? Drug Metab Dispos 35(12), 2159\u201365 (2007).","journal-title":"Drug Metab Dispos"},{"key":"50468_CR26","unstructured":"Fujitsu. ADMEWORKS DDI simulator. Available at, http:\/\/www.fqs.pl\/chemia\/produkty\/admeworks-ddi-simulator."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50468-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:56:22Z","timestamp":1671285382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50468-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50468"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50468-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"22 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13941"}}